Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Ventricular fibrillation frequency from implanted cardioverter defibrillator devices
Europace, 06/25/09
Panfilov I et al. – The dominant frequency (DF) of short intervals of induced ventricular fibrillation (VF) is highly reproducible and is sensitive to pharmacologic interventions that extend effective refractory period. Such estimates of DF may thus have clinical utility and in pts with implanted cardioverter defibrillator devices (ICDs) provide a means of investigating mechanisms underlying the initiation and early phases of VF.
Methods- Study of the reproducibility of the DF during separate VF events on stored electrograms (EGMs) from ICDs
- Assessment of 82 pts with a Medtronic ICD who had 2 induced VF episodes during ICD testing
- Extraction of EGMs recorded during both episodes
- Determination of DF using fast Fourier transform
- Mean DF for population: 4.7 ± 0.6 Hz, corresponding to 213-ms cycle length
- First and second VF episodes highly correlated, showing highly reproducible DF
- DF significantly lower for 18 pts on Class III agents vs remaining 63
- DF of ischemic heart disease pts did not differ from that of dilated cardiomyopathy pts
Today in Arrhythmias/EP...keeping you current
Receive free subspecialty "5-minute updates" via email
Acute Coronary Syndromes: Diagnosis and Management, Part I
Mayo Clinic Proceedings, 10/05/09
Acute medical management of the non-ST-segment elevation acute coronary syndromes (NSTE-ACS) in older patients
Archives of Gerontology and Geriatrics, 10/14/09
New Anticoagulants in Atrial Fibrillation
Seminars in Thrombosis and Hemostasis, 10/02/09
Today in Interventional...keeping you current
Receive free subspecialty "5-minute updates" via email
Effectiveness of Two-Year Clopidogrel + Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (from the TYCOON [Two-Year ClOpidOgrel Need] Study)
The American Journal of Cardiology, 11/05/09
Carotid artery stenting vs. endarterectomy
European Heart Journal, 10/30/09
Dofetilide is safe and effective in preventing atrial fibrillation recurrences in patients accepted for catheter ablation
Europace, 10/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


